👀 Ones to watch: Undervalued stocks to buy before they report Q3 earningsSee Undervalued Stocks

Democrat to vote against bill restricting China's WuXi Biologics, BGI

Published 09/06/2024, 11:30 PM
Updated 09/06/2024, 11:35 PM
© Reuters. FILE PHOTO: A sign outside a Wuxi AppTec facility is pictured, in San Diego, U.S., March 25, 2024. REUTERS/Michael Erman/ File Photo
2269
-

By Karen Freifeld

(Reuters) - An influential Democratic U.S. congressman said on Friday that he will vote against legislation that would restrict business with China's WuXi Biologics (HK:2269), BGI and other biotech companies on national security grounds.

Rep. Jim McGovern of Massachusetts, the ranking member on the House Rules committee, told Reuters he is trying to convince colleagues to join him in opposition.

McGovern said there was no process for how companies were included in the legislation, and that he could not get a straight answer for why Wuxi Biologics was added. The company is building a facility in his district.

The Biosecure Act is scheduled for a vote on Monday by the U.S. House of Representatives. Supporters say the legislation, which would subject the companies to federal contracting bans, is needed to protect Americans' personal health and genetic information as well as U.S. pharmaceutical supply chains.

McGovern, the top House Democrat on the Congressional-Executive Commission on China and a critic of China's human rights abuses, said, "Companies providing sensitive information to the Chinese government is a real and important issue."

"But the bottom line is, this is a lousy bill."

The bill is scheduled to be voted on under a process which limits debate, does not allow for amendments and requires a two-thirds majority vote for passage.

A spokesperson for the House Select Committee on China said that "biotech companies beholden to our foremost adversary, the Chinese Communist Party, pose a tremendous national security risk" and that WuXi Biologics, BGI and WuXi AppTec have a demonstrated history of working with the party.

The legislation also identifies WuXi AppTec, MGI and Complete Genomics as companies of concern.

© Reuters. FILE PHOTO: A sign outside a Wuxi AppTec facility is pictured, in San Diego, U.S., March 25, 2024. REUTERS/Michael Erman/ File Photo

The companies deny posing any threat to U.S. national security and each says they should not be included in the bill.

The legislation must pass both the House and Senate before President Joe Biden could sign it into law.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.